Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to COLUCCI: Alpha-adrenergic receptor blockade with prazosin: consideration of hypertension,.... (0.17 sec) 

Alpha-adrenergic receptor blockade with prazosin: consideration of hypertension, heart …


WS COLUCCI - Annals of Internal Medicine, 1982 - Am Coll Physicians
Prazosin, an orally active alpha-1 selective adrenergic antagonist, has been of
value in treating patients with hypertension and congestive heart failure. In
contrast to non-subtype-selective alpha-adrenergic antagonists and ...
Cited by 55 - Related articles - All 2 versions

Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart …


L Stein, DP Henry, MH Weinberger - The American journal of medicine, 1981 - ncbi.nlm.nih.gov
To investigate the mechanism of pharmacodynamic tolerance reported to occur
during prazosin therapy of chronic congestive heart failure, we measured plasma
norepinephrine, plasma epinephrine, plasma renin activity (PRA) and plasma ...
Cited by 18 - Related articles

Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in …


B Ogasawara, K Ogawa, H Hayashi, H Sassa - Clinical Pharmacology & Therapeutics, 1981 - nature.com
A single oral dose of 1.0 to 2.0 mg prazosin was given to 14 patients with
congestive heart failure to assess its effect. Prazosin increased cardiac index
(+27.5%) and decreased pulmonary arterial diastolic pressure (–29.1%), ...
Cited by 8 - Related articles - All 2 versions

Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart …


O Bertel, F Burkart, FR Bühler - American heart journal, 1981 - ncbi.nlm.nih.gov
Twelve patients with severe chronic congestive heart failure (CHF) (NYHA class
III and IV) resistant to digitalis and diuretics were treated with the
postsynaptic alpha-blocking agent prazosin (PZ) (3 to 20 mg/day). In 11 ...
Cited by 10 - Related articles

Methyldopa. Mechanisms and treatment 25 years later.


ED Frohlich - Archives of internal medicine, 1980 - ncbi.nlm.nih.gov
Methyldopa, an adrenergic-inhibiting compound, has been used for over 25 years
as a safe and effective antihypertensive agent. The postulated mechanisms for
the antihypertensive action of this compound have been varied and parallel ...
Cited by 21 - Related articles

The cardiovascular effects of trimazosin.


JW Constantine, HJ Hess - European journal of pharmacology, 1981 - ncbi.nlm.nih.gov
Trimazosin, a quinazoline related to the antihypertensive agent prazosin, was
studied in anesthetized animals and isolated tissue preparations for effects
related to cardiovascular activity. In cats, there was no evidence for ...
Cited by 24 - Related articles

Feocromocitoma: atualização diagnóstica e terapêutica


S Faiçal, D Shiota - Revista da Associação Médica Brasileira, 1997 - SciELO Brasil
A incidência destes tumores situa-se em torno de 0,1% nos hipertensos
diastólicos, sendo mais freqüentes entre a 3 a e 5 a décadas de vida, e com
incidência ligeiramente maior em mulheres que em homens. Dentre eles, mais ...
Cited by 3 - Related articles - Cached - All 5 versions

[CITATION] Prazosin


RM Graham, WA Pettinger - N Engl J Med, 1979
Cited by 88 - Related articles

[CITATION] Phaeochromocytoma


AS Hall, SG Ball - Netherlands journal of medicine, 1993 - cat.inist.fr
Phaeochromocytoma. AS HALL, SG BALL Netherlands journal of medicine 43,
29-38, Van zuiden, 1993. Surrénale pathologie; Adrenal gland ...
Cited by 5 - Related articles - All 2 versions

[CITATION] Clinical pharmacology of prazosin used alone or in combination in the therapy of …


RM Graham, J Mulvihill-Wilson - J Cardiovasc Pharmacol, 1980
Cited by 9 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google